scholarly journals Dependence of cardiovascular diseases mortality on helioseismic indicators in the Sheki region of the Azerbaijan Republic

2022 ◽  
Vol 99 (7-8) ◽  
pp. 444-450
Author(s):  
L. G. Efendiyeva
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Cardiovascular Diseases ◽  
Acute Heart Failure ◽  
Seismic Waves ◽  
Hypertensive Crisis ◽  
Close Correlation ◽  
Coronary Syndrome ◽  
The Republic ◽  
Age Range

Aim. To study the dependence of cardiovascular diseases mortality on geophysical and seismic indicators in the Sheki region of the Azerbaijan Republic.Material and methods. In 2013, seismological information was obtained from 35 telemetry stations, which included a review of the seismic setting of the republic, the distribution of seismic waves, the dynamics of seismic processes, the intensity of earthquakes, magnitude, etc. Based on the spatial distribution of the focal zones identifi ed by weak seismicity and the magnitudes of the maximum possible earthquakes in them, a map of the seismic hazard of the territory of Azerbaijan was compiled. To analyze the connection with diseases in the Sheki region, 742 case histories of patients (48.8% — 362 men and 51.2% — 380 women) who died in 2013 from various diseases, were analyzed.Results and discussion. Statistically signifi cant (p < 0.001), more deaths among men were from acute coronary syndrome (63.3%), from acute heart failure (46.0%) and from hypertensive crisis (HС) (45.3%). 59.3% died from acute cerebrovascular accident, 54.7% died from a hypertensive crisis and 54,0% from acute heart failure among women. Statistically signifi cant number of deaths was in the age range of 70–79 years old and 80–89 years old.The largest number of deaths was at a depth of 11–20 km — 20.6%, 21–30 km — 16.7%, less than 10 km — 10.5%. When the depth of the process was less than 10 km, the largest percentage of mortality was from acute coronary syndrome — 24.4%, with the depth of 11–20 km — from hypertensive process (40.5%); 24.2% died from heart failure.Conclusion. Thus, there is a close correlation between geomagnetic changes and CVD mortality in Sheki region of Azerbaijan. It is realized in the form of an increase in the frequency of cases and deaths, and the number of these cases is highly dependent on patients’ age.

scholarly journals The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion

2016 ◽  
Vol 218 ◽  
pp. 150-157 ◽  
Author(s):  
Markku S. Nieminen ◽  
Michael Buerke ◽  
Alain Cohen-Solál ◽  
Susana Costa ◽  
István Édes ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Acute Heart Failure ◽  
Expert Consensus ◽  
Coronary Syndrome ◽  
Consensus Opinion

Study on Heart Failure Patients Admitted in National Institute of Cardiovascular Diseases

2021 ◽  
Vol 13 (2) ◽  
pp. 172-176
Author(s):  
Nur Alam ◽  
Abdullah Al Shafi Majumder
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Heart Disease ◽  
Cardiovascular Diseases ◽  
Epidemiological Studies ◽  
Clinical Syndrome ◽  
Cross Sectional ◽  
Common Cause ◽  
Heart Failure Patients ◽  
Coronary Syndrome

Background: Heart failure is a complex clinical syndrome that arises secondary to abnormalities of cardiac structure and/or function (inherited or acquired) that impair the ability of the left ventricle to fill or eject blood. There is a paucity of data on characteristics of the patients of heart failure admitted in hospitals in terms of demographic and etiological information. So, this study aimed to see the disease burden of heart failure patients and the age and sex specific prevalence of heart failure among patients admitted into NICVD and to identify the etiological pattern of diseases leading to heart failure with associated comorbid factors. Methods: It was a cross sectional study carried out at National Institute of Cardiovascular Diseases (NICVD) Dhaka Bangladesh and was conducted from January 2015 to December 2015. Total 400 heart failure patients were taken. Results: The mean age of the patients were 54 ± 14 years ranging from 16 to 95 years with a high preponderance of male. Most the patient population was in the age group of 51- 60 years (29.5%). 79% of the cases were male & 21% female by gender specification. Ischaemic cardiomyopathy (ICM) was found to be the common cause of heart failure (n=153, 40.75%) followed by Acute coronary syndrome (32.5%) and Valvular heart disease (18.25%). The patients with heart failure having acute coronary syndrome (n=107) had hypertension (46.8%) as the most prevalent major risk factor. In the present study only 11% patient had heart failure with preserved ejection fraction. Mortality rate of the study population were 6.3%. Conclusion: In this study, the most common cause of heart failure is ischaemic heart disease. So, patients of acute and chronic ischemic heart disease patients should be treated and follow up with care. Clinical and epidemiological studies are needed to explore further. Cardiovasc. j. 2021; 13(2): 172-176

Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome

2009 ◽  
Vol 20 (4) ◽  
pp. 274-280 ◽  
Author(s):  
Luisa De Gennaro ◽  
Natale Daniele Brunetti ◽  
Rosa Bungaro ◽  
Deodata Montrone ◽  
Andrea Cuculo ◽  
...  
Keyword(s):  
Heart Failure ◽  
At Risk ◽  
Acute Coronary Syndrome ◽  
Acute Heart Failure ◽  
Carbohydrate Antigen ◽  
Carbohydrate Antigen 125 ◽  
Coronary Syndrome ◽  
Patients At Risk

scholarly journals Acute heart failure precipitated by acute coronary syndrome - patient characteristics, management and survival

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. 1721-1721
Author(s):  
T. Tarvasmaki ◽  
V.- P. Harjola ◽  
J. Tolonen ◽  
K. Siirila-Waris ◽  
M. S. Nieminen ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Acute Heart Failure ◽  
Acute Coronary Syndrome Patient ◽  
Patient Characteristics ◽  
Syndrome Patient ◽  
Coronary Syndrome

45 Frailty at Discharge is a Marker of End-of-Life following Admission with Acute Coronary Syndrome or Acute Heart Failure

Heart ◽  
2015 ◽  
Vol 101 (Suppl 4) ◽  
pp. A26.1-A26
Author(s):  
Martin Denvir ◽  
Say How Teoh ◽  
Marion Pender ◽  
Natalie Lane ◽  
Stephen Fenning ◽  
...  
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
End Of Life ◽  
Acute Heart Failure ◽  
Coronary Syndrome

scholarly journals Evaluation of Procalcitonin Levels in Patients with Various Forms of Acute Coronary Syndrome, Depending on the Presence of Adverse Hospital Outcomes

2021 ◽  
Vol 17 (3) ◽  
pp. 456-461
Author(s):  
O. M. Drapkina ◽  
V. A. Zakharova
Keyword(s):  
Heart Failure ◽  
Acute Coronary Syndrome ◽  
Unstable Angina ◽  
Acute Heart Failure ◽  
Cardiovascular Death ◽  
Adverse Outcomes ◽  
Hospital Outcomes ◽  
St Segment Elevation ◽  
Coronary Syndrome ◽  
Informed Consent Form

Aim. to study the levels of procalcitonin in patients with various forms of acute coronary syndrome (ACS), depending on the presence of adverse hospital outcomes.Materials and Methods. The study included 222 patients admitted to the emergency cardiology department with a diagnosis of ACS in the period from March 2014. until January 2017. Of these, 106 (47.7 %) patients were diagnosed with unstable angina (NS) and 116 (52.3%) with myocardial infarction (MI). Non ST segment elevation MI (NSTEMI) was diagnosed in 47 (40.5%) patients with MI, and ST elevation MI (STEMI) – in 69 (59.5%) patients with MI. After the assessment of the patient's compliance with the criteria for inclusion/exclusion in the study, the procedure for signing the patient's informed consent form was carried out. The protocol of the study was approved by the local Ethics committee of the M. E. Zhadkevich State Clinical Hospital. In each study subgroup, the presence of adverse outcomes during the current hospitalization was assessed: cardiovascular death, nonfatal MI, nonfatal acute cerebrovascular accident, acute heart failure, as well as a combined endpoint, including all of the listed adverse outcomes. All patients, in addition to routine laboratory methods of investigation, were examined for the level of procalcitonin at admission to the hospital, on 2-3 and 4-5 days.Results. Patients with MI compared to patients with NS were characterized by a large number of registered endpoints in general (24.1% vs. 6.6%, p<0.001), while in the group of patients with MI, cardiovascular death was more often recorded (10.3% vs. 0.9%, p<0.001) and acute heart failure (12.9% vs. 5.6%, p=0.009). Patients with MI, in particular with STEMI, who had adverse hospital outcomes, were characterized by statistically significantly higher levels of procalcitonin compared to patients without adverse hospital outcomes. Patients with STEMI showed significantly higher levels of procalcitonin at all stages of the disease, and patients with MI-only at 2-3 and 4-5 days. There were no statistically significant differences in the level of procalcitonin at all stages of the disease in patients with NSTEMI and with unstable angina, depending on the hospital outcomes.Conclusion. Elevated procalcitonin levels in patients with MI, in particular with STEMI, are associated with adverse hospital outcomes; for other forms of ACS, no statistically significant differences were observed with different hospital outcomes.

Sign in / Sign up

Export Citation Format

Share Document